11-31791034-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001368894.2(PAX6):​c.1075-174G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.743 in 762,266 control chromosomes in the GnomAD database, including 215,595 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.69 ( 37626 hom., cov: 32)
Exomes 𝑓: 0.76 ( 177969 hom. )

Consequence

PAX6
NM_001368894.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.655

Publications

20 publications found
Variant links:
Genes affected
PAX6 (HGNC:8620): (paired box 6) This gene encodes paired box protein Pax-6, one of many human homologs of the Drosophila melanogaster gene prd. In addition to a conserved paired box domain, a hallmark feature of this gene family, the encoded protein also contains a homeobox domain. Both domains are known to bind DNA and function as regulators of gene transcription. Activity of this protein is key in the development of neural tissues, particularly the eye. This gene is regulated by multiple enhancers located up to hundreds of kilobases distant from this locus. Mutations in this gene or in the enhancer regions can cause ocular disorders such as aniridia and Peter's anomaly. Use of alternate promoters and alternative splicing results in multiple transcript variants encoding different isoforms. Interestingly, inclusion of a particular alternate coding exon has been shown to increase the length of the paired box domain and alter its DNA binding specificity. Consequently, isoforms that carry the shorter paired box domain regulate a different set of genes compared to the isoforms carrying the longer paired box domain. [provided by RefSeq, Mar 2019]
PAX6 Gene-Disease associations (from GenCC):
  • aniridia 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • PAX6-related ocular dysgenesis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Peters anomaly
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • coloboma, ocular, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • diabetes mellitus
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • aniridia-cerebellar ataxia-intellectual disability syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • foveal hypoplasia-presenile cataract syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated aniridia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated optic nerve hypoplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant keratitis
    Inheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 11-31791034-C-T is Benign according to our data. Variant chr11-31791034-C-T is described in ClinVar as Benign. ClinVar VariationId is 674009.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.799 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAX6NM_001368894.2 linkc.1075-174G>A intron_variant Intron 12 of 13 ENST00000640368.2 NP_001355823.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAX6ENST00000640368.2 linkc.1075-174G>A intron_variant Intron 12 of 13 5 NM_001368894.2 ENSP00000492024.1 P26367-2

Frequencies

GnomAD3 genomes
AF:
0.689
AC:
104691
AN:
151948
Hom.:
37613
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.499
Gnomad AMI
AF:
0.870
Gnomad AMR
AF:
0.642
Gnomad ASJ
AF:
0.786
Gnomad EAS
AF:
0.486
Gnomad SAS
AF:
0.750
Gnomad FIN
AF:
0.772
Gnomad MID
AF:
0.697
Gnomad NFE
AF:
0.805
Gnomad OTH
AF:
0.712
GnomAD4 exome
AF:
0.757
AC:
461623
AN:
610200
Hom.:
177969
Cov.:
7
AF XY:
0.762
AC XY:
248946
AN XY:
326622
show subpopulations
African (AFR)
AF:
0.511
AC:
8589
AN:
16824
American (AMR)
AF:
0.557
AC:
19174
AN:
34452
Ashkenazi Jewish (ASJ)
AF:
0.777
AC:
15619
AN:
20104
East Asian (EAS)
AF:
0.492
AC:
15671
AN:
31834
South Asian (SAS)
AF:
0.759
AC:
47877
AN:
63094
European-Finnish (FIN)
AF:
0.769
AC:
26233
AN:
34108
Middle Eastern (MID)
AF:
0.754
AC:
2615
AN:
3470
European-Non Finnish (NFE)
AF:
0.808
AC:
302316
AN:
374242
Other (OTH)
AF:
0.734
AC:
23529
AN:
32072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
5639
11278
16917
22556
28195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2444
4888
7332
9776
12220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.689
AC:
104736
AN:
152066
Hom.:
37626
Cov.:
32
AF XY:
0.687
AC XY:
51052
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.498
AC:
20647
AN:
41438
American (AMR)
AF:
0.642
AC:
9820
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.786
AC:
2726
AN:
3468
East Asian (EAS)
AF:
0.487
AC:
2510
AN:
5156
South Asian (SAS)
AF:
0.751
AC:
3615
AN:
4816
European-Finnish (FIN)
AF:
0.772
AC:
8170
AN:
10584
Middle Eastern (MID)
AF:
0.692
AC:
202
AN:
292
European-Non Finnish (NFE)
AF:
0.805
AC:
54745
AN:
68000
Other (OTH)
AF:
0.715
AC:
1509
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1518
3035
4553
6070
7588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
818
1636
2454
3272
4090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.762
Hom.:
84895
Bravo
AF:
0.667
Asia WGS
AF:
0.605
AC:
2106
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
5.3
DANN
Benign
0.83
PhyloP100
0.66
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071754; hg19: chr11-31812582; API